PharVision Advisers »

Hercules Technology Growth Capital shares owned by PharVision Advisers

Quarter-by-quarter ownership of Hercules Technology Growth Capital (HTGC) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Hercules Technology Growth Capital

Tip: Access up to 7 years of quarterly data

All positions including Hercules Technology Growth Capital held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hercules Technology Growth Capital by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $203k 10k 20.09

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Hercules Technology Growth Capital

Van Eck Associates Corp.
Sound Income Strategies
Two Sigma Advisers
LPL Financial
Two Sigma Investments
Millennium Management
BlackRock
Muzinich & Co
UBS Group
Citadel Advisors
Legal & General Group
Qube Research & Technologies
Sumitomo Mitsui Trust Holdings
Franklin Resources
Melia Wealth

View all funds holding Hercules Technology Growth Capital